Search
Filter Results
Displaying 741–750 of 865 results for “vision connection”
-
May 1, 2024
Foundation Fighting Blindness To Host Annual 2024 Gala Night for Sight
Foundation NewsThe May 9th gala will raise awareness and fund research leading to treatments and cures for blinding diseases.
-
Apr 19, 2024
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
Research NewsThe company’s innovative Gene Coding™ platform enables seamless insertion of DNA into selective genomic locations.
-
VISIONS 2024, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research.
-
Feb 21, 2024
jCyte Announces Plans to Launch Phase 3 Clinical Trial of Cell Therapy for RP
Research NewsKnown as retinal progenitors, the company’s jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and other retinal diseases.
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
Research NewsACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
The goal of Envisioning a Path to Hope is to expand connections with eye care professionals all over the U.S. This important initiative will provide an opportunity for all of our volunteers and partners to share the Foundation with eye care professionals within their personal network.
-
Nov 13, 2023
IRD Community Loses Usher Syndrome Research Trailblazer William Kimberling, PhD
Beacon StoriesDr. Kimberling helped discover the identification and characterization of several genes that cause Usher syndrome.
-
Oct 25, 2023
Foundation Fighting Blindness and Eone Announce Partnership
Foundation NewsTogether, the Foundation Fighting Blindness and Eone are launching a new limited-edition tactile timepiece watch, the ChangeMaker.
-
-
Sep 18, 2023
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
Research NewsThe company is also launching modifier gene therapy clinical trials for GA and Stargardt disease